Analyst
Shareholder Proponent
Equibles does not estimate personal net worth.
Laura Boudreau is recorded as Analyst at Shareholder Proponent. Laura Boudreau has spoken on 1 investor event across 1 company, most recently for Gilead Sciences, Inc. on April 30, 2026. The companies whose calls Laura Boudreau spoke on are classified in the Healthcare sector.
“Shareholder H Health Care Foundation, that's AHF, urges Gilead shareholders to vote for Proposal 6, submitted by AHF and co-filer Academica Pension. AHF proposes a board-sponsored independent study of the effects of Gilead's patent extension strategies.”
Shareholder Proponent
Analyst
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
